The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression

BackgroundThe COMT gene is located on chromosome 22q11, a region strongly implicated in the aetiology of several psychiatric disorders, in particular schizophrenia. Previous research has suggested that activity and expression of COMT is altered in schizophrenia, and is mediated by one or more polymorphisms within the gene, including the functional Val158Met polymorphism.MethodIn this study we examined the expression levels of COMT mRNA using quantitative RT-PCR in 60 post mortem cerebellum samples derived from individuals with schizophrenia, bipolar disorder, depression, and no history of psychopathology. Furthermore, we have examined the methylation status of two CpG sites in the promoter region of the gene.ResultsWe found no evidence of altered COMT expression or methylation in any of the psychiatric diagnoses examined. We did, however, find evidence to suggest that genotype is related to COMT gene expression, replicating the findings of two previous studies. Specifically, val158met (rs165688; Val allele) rs737865 (G allele) and rs165599 (G allele) all showed reduced expression (P < 0.05). Finally, we observe a strong sexual dimorphism in COMT expression, with females exhibiting significantly greater levels of COMT mRNA.ConclusionThe expression of COMT does not appear to be altered in the cerebellum of individuals suffering from schizophrenia, bipolar disorder or depression, but does appear to be influenced by single nucleotide polymorphisms within the gene.

[1]  David Goldman,et al.  Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5′ nuclease assay , 2004, Psychopharmacology.

[2]  P. Männistö,et al.  Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. , 1999, Pharmacological reviews.

[3]  A. Petronis.  The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis , 2004, Biological Psychiatry.

[4]  Michael C O'Donovan,et al.  A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. , 2003, American journal of human genetics.

[5]  A. Caspi,et al.  Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction , 2005, Biological Psychiatry.

[6]  Lin He,et al.  Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: A large-scale association study plus meta-analysis , 2005, Biological Psychiatry.

[7]  R. Weinshilboum,et al.  Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. , 1999, Annual review of pharmacology and toxicology.

[8]  R. Murray,et al.  Preferential transmission of the high activity allele of COMT in schizophrenia , 1996, Psychiatric genetics.

[9]  Jurg Ott,et al.  Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder , 1999, Biological Psychiatry.

[10]  A. Sampson,et al.  Dopamine transporter immunoreactivity in monkey cerebral cortex: Regional, laminar, and ultrastructural localization , 2001, The Journal of comparative neurology.

[11]  S. Faraone,et al.  Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. , 2003, The American journal of psychiatry.

[12]  A. Malhotra,et al.  A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. , 2002, The American journal of psychiatry.

[13]  J. Beckmann,et al.  A highly significant association between a COMT haplotype and schizophrenia. , 2002, American journal of human genetics.

[14]  Paul J. Harrison,et al.  Catechol‐o‐methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression , 2004, Synapse.

[15]  A. Petronis,et al.  Human morbid genetics revisited: relevance of epigenetics. , 2001, Trends in genetics : TIG.

[16]  J. Ott,et al.  Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Egan,et al.  Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. , 2004, American journal of human genetics.

[18]  R. Murray,et al.  Catechol‐O‐methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families , 1997, Psychiatric genetics.

[19]  N. Hayward,et al.  Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia , 2005, Molecular Psychiatry.

[20]  K K Kidd,et al.  COMT haplotypes suggest P2 promoter region relevance for schizophrenia , 2004, Molecular Psychiatry.

[21]  E. Pehek,et al.  Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat , 2002, Brain Research.

[22]  R. Yolken,et al.  The Stanley Foundation brain collection and Neuropathology Consortium , 2000, Schizophrenia Research.

[23]  I. Ulmanen,et al.  Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.

[24]  C. Creveling.  The Role of Catechol-O-Methyltransferase in the Inactivation of Catecholestrogen , 2003, Cellular and Molecular Neurobiology.

[25]  Michael J Owen,et al.  Recent advances in the genetics of schizophrenia. , 2003, Human molecular genetics.

[26]  J. Duan,et al.  Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia , 2005, Molecular Psychiatry.

[27]  R. Wise,et al.  Dopamine Uptake through the Norepinephrine Transporter in Brain Regions with Low Levels of the Dopamine Transporter: Evidence from Knock-Out Mouse Lines , 2002, The Journal of Neuroscience.

[28]  R. Weinshilboum,et al.  Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.

[29]  T. Terao,et al.  Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics , 1998, Neuroscience Letters.

[30]  J. Mallet,et al.  Linkage disequilibrium on the COMT gene in French schizophrenics and controls. , 1999, American journal of medical genetics.

[31]  A. Olek,et al.  A modified and improved method for bisulphite based cytosine methylation analysis. , 1996, Nucleic acids research.

[32]  C. Benkelfat,et al.  Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. , 2002, Archives of general psychiatry.

[33]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Daniel R Weinberger,et al.  Catechol O-Methyltransferase (COMT) mRNA Expression in the Dorsolateral Prefrontal Cortex of Patients with Schizophrenia , 2003, Neuropsychopharmacology.

[35]  D. Pfaff,et al.  Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Shiva M. Singh,et al.  Site‐specific cytosine methylation in S‐COMT promoter in 31 brain regions with implications for studies involving schizophrenia , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.